Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 4
1984 3
1985 1
1986 3
1987 3
1988 1
1989 3
1990 1
1991 1
1992 5
1993 3
1994 3
1995 1
1996 4
1997 2
1998 3
1999 5
2000 4
2001 1
2002 2
2003 2
2004 5
2005 1
2006 3
2007 5
2008 4
2009 3
2010 3
2011 5
2012 5
2013 9
2014 14
2015 8
2016 13
2017 9
2018 14
2019 12
2020 10
2021 4
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

150 results
Results by year
Filters applied: . Clear all
Page 1
Infantile gangliosidoses: Mapping a timeline of clinical changes.
Jarnes Utz JR, Kim S, King K, Ziegler R, Schema L, Redtree ES, Whitley CB. Jarnes Utz JR, et al. Among authors: whitley cb. Mol Genet Metab. 2017 Jun;121(2):170-179. doi: 10.1016/j.ymgme.2017.04.011. Epub 2017 Apr 29. Mol Genet Metab. 2017. PMID: 28476546 Free PMC article. Clinical Trial.
A novel gene editing system to treat both Tay-Sachs and Sandhoff diseases.
Ou L, Przybilla MJ, Tăbăran AF, Overn P, O'Sullivan MG, Jiang X, Sidhu R, Kell PJ, Ory DS, Whitley CB. Ou L, et al. Among authors: whitley cb. Gene Ther. 2020 May;27(5):226-236. doi: 10.1038/s41434-019-0120-5. Epub 2020 Jan 2. Gene Ther. 2020. PMID: 31896760 Free PMC article.
Agalsidase-beta therapy for advanced Fabry disease: a randomized trial.
Banikazemi M, Bultas J, Waldek S, Wilcox WR, Whitley CB, McDonald M, Finkel R, Packman S, Bichet DG, Warnock DG, Desnick RJ; Fabry Disease Clinical Trial Study Group. Banikazemi M, et al. Among authors: whitley cb. Ann Intern Med. 2007 Jan 16;146(2):77-86. doi: 10.7326/0003-4819-146-2-200701160-00148. Epub 2006 Dec 18. Ann Intern Med. 2007. PMID: 17179052 Free article. Clinical Trial.
Chitotriosidase as a biomarker for gangliosidoses.
Kim S, Whitley CB, Jarnes JR. Kim S, et al. Among authors: whitley cb. Mol Genet Metab Rep. 2021 Oct 1;29:100803. doi: 10.1016/j.ymgmr.2021.100803. eCollection 2021 Dec. Mol Genet Metab Rep. 2021. PMID: 34646735 Free PMC article.
Gene therapy for neurologic manifestations of mucopolysaccharidoses.
Wolf DA, Banerjee S, Hackett PB, Whitley CB, McIvor RS, Low WC. Wolf DA, et al. Among authors: whitley cb. Expert Opin Drug Deliv. 2015 Feb;12(2):283-96. doi: 10.1517/17425247.2015.966682. Epub 2014 Dec 16. Expert Opin Drug Deliv. 2015. PMID: 25510418 Free PMC article. Review.
Adams-Oliver syndrome revisited.
Whitley CB, Gorlin RJ. Whitley CB, et al. Am J Med Genet. 1991 Sep 1;40(3):319-26. doi: 10.1002/ajmg.1320400315. Am J Med Genet. 1991. PMID: 1951437 Review.
The juvenile gangliosidoses: A timeline of clinical change.
King KE, Kim S, Whitley CB, Jarnes-Utz JR. King KE, et al. Among authors: whitley cb. Mol Genet Metab Rep. 2020 Nov 14;25:100676. doi: 10.1016/j.ymgmr.2020.100676. eCollection 2020 Dec. Mol Genet Metab Rep. 2020. PMID: 33240792 Free PMC article.
Immune response to enzyme replacement therapies in lysosomal storage diseases and the role of immune tolerance induction.
Kishnani PS, Dickson PI, Muldowney L, Lee JJ, Rosenberg A, Abichandani R, Bluestone JA, Burton BK, Dewey M, Freitas A, Gavin D, Griebel D, Hogan M, Holland S, Tanpaiboon P, Turka LA, Utz JJ, Wang YM, Whitley CB, Kazi ZB, Pariser AR. Kishnani PS, et al. Among authors: whitley cb. Mol Genet Metab. 2016 Feb;117(2):66-83. doi: 10.1016/j.ymgme.2015.11.001. Epub 2015 Nov 10. Mol Genet Metab. 2016. PMID: 26597321 Review.
150 results